| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −9.9× | −1.7× | |
| Price / Book | 1.0× | 2.0× | |
| Price / Sales | 14.9× | 3.9× | |
| Price / Free cash flow | −0.4× | −1.6× | |
| EV / EBITDA | −0.2× | −1.2× | |
| Earnings yield | −10.1% | −14.4% | |
| Free cash flow yield | −226.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,286.97 | +3.76% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.93 | +2.03% | $624B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.00 | +1.88% | $508.93B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.58 | +3.12% | $376.61B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.14 | +3.14% | $365.49B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.53 | +2.22% | $283.03B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.76 | +2.93% | $261.73B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $688.44 | +1.33% | $254.55B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $436.33 | +2.68% | $235.89B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.12 | +1.99% | $193.58B | 22.3× | 37.5% | +29.9% |
